Work

Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression

Year: 2022

Type: article

Source: British Journal of Cancer

DOI: 10.1038/s41416-022-01796-5

Authors: Mark Sellin, Ryan Mack, Matthew C. Rhodes, Lei Zhang, Stephanie Berg, Kanak Joshi, Shanhui Liu, Wei Wei, Peter Breslin S. J., Peter Larsen, Richard E. Taylor, Jiwang Zhang

Institutions: Loyola University Medical Center, Loyola Medicine, University of Notre Dame, Mike and Josie Harper Cancer Research Institute, Soochow University, Loyola University Chicago, Lanzhou University Second Hospital

Language: English

Topic: RNA Research and Splicing

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, Walther Cancer Foundation, Loyola University Chicago, National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institute of General Medical Sciences

Awards: Splicing Modulators for Rare Disease Indications, G1768540141, Splicing Modulators for Rare Disease Indications, G2089033593, G320806863, G3502139528, Systematic identification of hematopoietic stem cell expansion factors, G5743282405, G6635656546, RIP1/RIP3-Calpain-Stat3 and NF-kappa B pathways in AML pathogenesis and treatment, G9000046967, G9000282763

OpenAlex ID: W4223890604

FWCI: 0.483

Cites: 106

Cited by: 11

Related to: 10